Trademark Overview
On Tuesday, March 10, 2026, a trademark application was filed for HIPEL with the United States Patent and Trademark Office. The USPTO has given the HIPEL trademark a serial number of 99693210. The federal status of this trademark filing is APPROVED FOR PUBLICATION as of Friday, July 10, 2026. This trademark is owned by SHANGHAI HONGENE BIOTECH CORPORATION. The HIPEL trademark is filed in the Treatment & Processing of Materials Services and Computer & Software Services & Scientific Services categories with the following description:
Chemical reagents processing; Custom biomanufacturing of pharmaceuticals; Custom manufacture of biopharmaceuticals; Custom manufacturing of pharmaceuticals; Cryopreservation services; Providing technical information in the field of pharmaceutical manufacturing; Manufacturing services for others in the field of siRNA synthesis; Custom manufacture of siRNA therapeutics; Custom manufacture of RNA utilizing proprietary enzymatic technologies to enable nucleic acid therapeutics development
Research and development of new products for others; Research and development of mRNA drugs; Laboratory research services in the field of gene expression; RNA interference technology research; Research and development of siRNA drugs; Circular RNA vaccine research; Research in the field of gene editing technology; Biological research; Medical and scientific research, namely, conducting clinical trials for others; Scientific research in the field of genetics; Research and development of small molecule RNA drugs
